Ocular Hypertension Withdrawn Phase 3 Trials for Latanoprost (DB00654)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01721707Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OHTreatment
NCT00283764Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceTreatment